High risk stigmata and treatment strategy for acute lower gastrointestinal bleeding: a nationwide study in Japan
- 14 February 2024
- journal article
- research article
- Published by Georg Thieme Verlag KG in Endoscopy
- Vol. 56 (04) , 291-301
Abstract
Background The rebleeding risks and outcomes of endoscopic treatment for acute lower gastrointestinal bleeding (ALGIB) may differ depending on the bleeding location, type, and etiology of stigmata of recent hemorrhage (SRH) but have yet to be fully investigated. We aimed to identify high risk endoscopic SRH and to propose an optimal endoscopic treatment strategy. Methods We retrospectively analyzed 2699 ALGIB patients with SRH at 49 hospitals (CODE BLUE-J Study), of whom 88.6 % received endoscopic treatment. Results 30-day rebleeding rates of untreated SRH significantly differed among locations (left colon 15.5 % vs. right colon 28.6 %) and etiologies (diverticular bleeding 27.5 % vs. others [e. g. ulcerative lesions or angioectasia] 8.9 %), but not among bleeding types. Endoscopic treatment reduced the overall rebleeding rate (adjusted odds ratio [AOR] 0.69; 95 %CI 0.49–0.98), and the treatment effect was significant in right-colon SRH (AOR 0.46; 95 %CI 0.29–0.72) but not in left-colon SRH. The effect was observed in both active and nonactive types, but was not statistically significant. Moreover, the effect was significant for diverticular bleeding (AOR 0.60; 95 %CI 0.41–0.88) but not for other diseases. When focusing on treatment type, the effectiveness was not significantly different between clipping and other modalities for most SRH, whereas ligation was significantly more effective than clipping in right-colon diverticular bleeding. Conclusions A population-level endoscopy dataset allowed us to identify high risk endoscopic SRH and propose a simple endoscopic treatment strategy for ALGIB. Unlike upper gastrointestinal bleeding, the rebleeding risks for ALGIB depend on colonic location, bleeding etiology, and treatment modality.Keywords
Funding Information
- the Advanced Research and Development Programs for Medical Innovation (PRIME) from AMED
- P-CREATE from AMED
- Smoking Research Foundation (http://dx.doi.org/10.13039/501100004330)
- JSPS KAKENHI Grant (20K08366)
- Grants-in-Aid for Research from the National Center for Global Health and Medicine (19A-2015)
- Takeda Science Foundation (http://dx.doi.org/10.13039/100007449)
- KAKENHI Grants-in-Aid for Scientific Research from JSPS
- The Ministry of Health, Labour and Welfare, Japan (19HB1003)
This publication has 28 references indexed in Scilit:
- Treatment strategies for reducing early and late recurrence of colonic diverticular bleeding based on stigmata of recent hemorrhage: a large multicenter studyGastrointestinal Endoscopy, 2022
- Endoscopic direct clipping versus indirect clipping for colonic diverticular bleeding: A large multicenter cohort studyUnited European Gastroenterology Journal, 2022
- Association of Obesity With Colonic Diverticulosis in WomenClinical Gastroenterology and Hepatology, 2020
- Principles of confounder selectionEuropean Journal of Epidemiology, 2019
- Comparison of Propensity Score Methods and Covariate AdjustmentJACC, 2017
- Risk factors for active bleeding from colonic angiodysplasia confirmed by colonoscopic observationInternational Journal of Colorectal Disease, 2016
- Natural history of definitive diverticular hemorrhage based on stigmata of recent hemorrhage and colonoscopic Doppler blood flow monitoring for risk stratification and definitive hemostasisGastrointestinal Endoscopy, 2016
- Colonoscopy With Clipping Is Useful in the Diagnosis and Treatment of Diverticular BleedingClinical Gastroenterology and Hepatology, 2012
- Anatomic Patterns, Patient Characteristics, and Clinical Outcomes in Ischemic Colitis: A Study of 313 Cases Supported by HistologyAmerican Journal of Gastroenterology, 2010
- Risk Factors for Mortality in Lower Intestinal BleedingClinical Gastroenterology and Hepatology, 2008